explore -WSS

explore

author：hotspot 2025-08-11 11:45:46 - browse：96

Sterile capsules for injection line up in a dispensing line — politics coverage from STAT — Adobe

WASHINGTON — The Senate Finance Committee has drafted a bipartisan bill to mitigate drug shortages by rewarding hospitals for business practices that ensure an adequate supply of drugs.

Drug shortages have been a persistent problem for years, and they’re worse than ever, according to a recent report by the American Society of Health-System Pharmacists. Shortages are primarily a problem for hospitals and doctors who regularly administer drugs, including oncologists who have been running out of common chemo drugs. Generic injectables account for 67% of shortages, and more than half of drugs in short supply cost less than $1 per unit, according to the Finance Committee.

Hospitals band together to negotiate drug prices by hiring group purchasing organizations. The biggest three GPOs are estimated to control about 90% of the market for drugs that hospitals buy. Finance Chair Ron Wyden (D-Ore.) said those GPOs can drive prices down so low that manufacturers stop making certain drugs or can’t afford to maintain their facilities, which then leads to manufacturing interruptions. Drugmakers also say GPOs can also be fickle, switching from one manufacturer to another over small savings, leaving drugmakers without the certainty they need to commit to making large volumes of product.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Sanofi CEO defends move to abandon profit guidance, boost research

explore

WSS

Study: New antibiotic targets gonorrhea as well as last existing drug

Diversify hospital leadership teams to protect BIPOC patient health

Medicare solvency divides Republicans at the presidential debate

STAT Executive Editor Rick Berke on STAT's 8th birthday

A new study sees potential in DNA sequencing of infants

FDA approves potent Eli Lilly obesity drug, Zepbound

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Palantir health business leans on meeting customers’ needs

New air purifier tech could be key to improving indoor air quality

Elizabeth Holmes on track for early release from her 11

23andMe had bad news about my health. I wish a person had delivered it

FDA approves Recor Medical high blood pressure device

BioMarin wins approval for gene therapy to treat hemophilia A

A clever new way to fix Medicaid and graduate medical education

Activists slam private health insurers over coverage restrictions

10 million people disenrolled from Medicaid over past six months

hotspot

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

Biotech incubator Curie.Bio graduates its first startup

NIH fellows want a pay raise. Will that mean less money for grants?

It's time to get medical device identifiers over the finish line

Senate panel clears PBM, hopsital reforms

explore

knowledge

knowledge

focus